tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CSPC Strikes US$1.2 Billion AstraZeneca Deal for Long-Acting Peptide and Obesity Drugs
Company AnnouncementsCSPC Strikes US$1.2 Billion AstraZeneca Deal for Long-Acting Peptide and Obesity Drugs
20h ago
CSPC Wins China’s First Clinical Green Light for In Vivo CAR-T Therapy
PremiumCompany Announcements
CSPC Wins China’s First Clinical Green Light for In Vivo CAR-T Therapy
1d ago
CSPC Pharmaceutical Grants 46.5 Million Restricted Shares to 727 Employees
PremiumCompany Announcements
CSPC Pharmaceutical Grants 46.5 Million Restricted Shares to 727 Employees
7d ago
CSPC Innovation Warns of 2025 Loss as R&D Surge Accelerates Drug Pipeline
PremiumCompany Announcements
CSPC Innovation Warns of 2025 Loss as R&D Surge Accelerates Drug Pipeline
15d ago
CSPC Wins U.S. FDA Nod for Trial of Novel Hypertension Drug SYH2072
PremiumCompany Announcements
CSPC Wins U.S. FDA Nod for Trial of Novel Hypertension Drug SYH2072
17d ago
CSPC Wins NMPA Acceptance for Prusogliptin–Metformin Combo in Diabetes Push
PremiumCompany AnnouncementsCSPC Wins NMPA Acceptance for Prusogliptin–Metformin Combo in Diabetes Push
18d ago
CSPC Wins China Trial Green Light for First Inhaled Nintedanib for Pulmonary Fibrosis
Premium
Company Announcements
CSPC Wins China Trial Green Light for First Inhaled Nintedanib for Pulmonary Fibrosis
28d ago
CSPC Wins China Clinical Trial Nod for Next-Generation Obesity Drug SYH2069
Premium
Company Announcements
CSPC Wins China Clinical Trial Nod for Next-Generation Obesity Drug SYH2069
1M ago
CSPC Wins China Trial Nod for First-in-Class Triple Diabetes Combination Therapy
PremiumCompany Announcements
CSPC Wins China Trial Nod for First-in-Class Triple Diabetes Combination Therapy
1M ago
CSPC Wins China Trial Nod for Potential Best-in-Class Aldosterone Synthase Inhibitor
PremiumCompany Announcements
CSPC Wins China Trial Nod for Potential Best-in-Class Aldosterone Synthase Inhibitor
1M ago
CSPC Wins NMPA Nod to Trial Daratumumab Biosimilar for Multiple Myeloma
PremiumCompany Announcements
CSPC Wins NMPA Nod to Trial Daratumumab Biosimilar for Multiple Myeloma
1M ago
CSPC Pharmaceutical Reshapes Top Management, Names Cai Lei as New CEO
PremiumCompany Announcements
CSPC Pharmaceutical Reshapes Top Management, Names Cai Lei as New CEO
1M ago
CSPC Pharmaceutical Updates Board and Committee Composition
PremiumCompany AnnouncementsCSPC Pharmaceutical Updates Board and Committee Composition
1M ago
CSPC Wins China Trial Green Light for Novel Oral Influenza Drug SYH2085
Premium
Company Announcements
CSPC Wins China Trial Green Light for Novel Oral Influenza Drug SYH2085
1M ago
CSPC’s Secukinumab Biosimilar Hits Phase III Equivalence Target in Psoriasis
Premium
Company Announcements
CSPC’s Secukinumab Biosimilar Hits Phase III Equivalence Target in Psoriasis
1M ago
CSPC Pharmaceutical Gains Approval for New Cancer Treatment Indication
PremiumCompany Announcements
CSPC Pharmaceutical Gains Approval for New Cancer Treatment Indication
2M ago
CSPC Innovation Seeks H Share Listing Amid Expansion Plans
PremiumCompany Announcements
CSPC Innovation Seeks H Share Listing Amid Expansion Plans
2M ago
CSPC Pharmaceutical Gains U.S. FDA Approval for JMT206 Clinical Trials
PremiumCompany Announcements
CSPC Pharmaceutical Gains U.S. FDA Approval for JMT206 Clinical Trials
2M ago
CSPC Pharmaceutical’s Semaglutide Injection Gains NMPA Acceptance
PremiumCompany Announcements
CSPC Pharmaceutical’s Semaglutide Injection Gains NMPA Acceptance
2M ago
CSPC’s Innovative Obesity Drug Receives U.S. Clinical Trial Approval
PremiumCompany AnnouncementsCSPC’s Innovative Obesity Drug Receives U.S. Clinical Trial Approval
2M ago
CSPC Pharmaceutical’s Antidepressant Drug Gains U.S. FDA Trial Approval
Premium
Company Announcements
CSPC Pharmaceutical’s Antidepressant Drug Gains U.S. FDA Trial Approval
2M ago
CSPC Pharmaceutical’s JMT206 Receives Clinical Trial Approval in China
Premium
Company Announcements
CSPC Pharmaceutical’s JMT206 Receives Clinical Trial Approval in China
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >